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Introduction
The increasing prevalence of ESBL-E in the community
is a cause of concern for hospitals. Early detection of
ESBL-E carriers on admission could allow timely imple-
mentation of control measures or appropriate selection
of antimicrobials.
Objectives
To describe the current prevalence of ESBL-E rates
upon admission to 4 different services at HUG, in the
context of a multicenter European study (R-Gnosis).
Methods
Patients admitted to 4 different services were screened
by rectal swabs on admission. From January 2014
through January 2015, patients admitted to 4 wards,
including: Ortho1 (sport traumatology), Ortho 2 (septic);
Geriatrics (2 wards) and patients undergoing elective
colorectal surgery (ECS) were screened from April
2013-October 2014.
Results
Overall, from 2394 admitted patients, 2136 were screened
on admission (89.2%). Median age was 67.3 years (SD
±20.9); 51.6% were male. Only 92/2136 (4.3%) had a pre-
viously known status of ESBL carriage. A total of 226/2136
(10.6%) patients were found to be ESBL-E carriers: E. coli
(n=166; 73.4%); K. pneumoniae (n=26; 11.5%) and other
Enterobacteriaceae (n=34; 15.0%). Among K. pneumonia
carriers on admission, 24/26 (92.3%), had a previous hos-
pitalization less than 12 months before admission screen-
ing and 21/26 (80.8%) had the previous hospitalization
within 3 months only. ESBL-E carriage was 83/981 (8.4%)
and 61/430 (14.2%) for Ortho 1 and 2 respectively; Geria-
trics, 42/371 (11.3%); and ECS, 41/354 (11.6%).
Conclusion
Overall 10.6% of patients screened were ESBL-E carriers
upon admission at HUG, mostly due to ESBL-producing
E. coli. Patients admitted to septic orthopedics, geriatrics
and ECS had a higher prevalence on admission. The
majority of ESBL- Klebsiella pneumonia carriers had a
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